Statin Use and Development and Progression of Nonalcoholic Fatty Liver Disease Based on Ultrasonography
Taking statin may decrease the risk of NAFLD occurrence and progression in the population with statin indication, suggesting the potential role of statin both in primary and secondary prevention strategies for NAFLD, especially among those with low or moderate ASCVD risk.
Authors
- Baoyu Feng (ORCID: https://orcid.org/0000-0003-1718-9025)
- Fengde Li
- Feipeng Cui (ORCID: https://orcid.org/0009-0000-4291-4028)
- Meihua Yin
- Yanqi Lan (ORCID: https://orcid.org/0000-0002-1607-1204)
- Shutong Wu
- Chenlu Yang (ORCID: https://orcid.org/0000-0002-0131-6475)
- Li Wang (ORCID: https://orcid.org/0000-0002-5595-2741)
- Guodong Wang (ORCID: https://orcid.org/0000-0002-0422-8999)
- Shouling Wu (ORCID: https://orcid.org/0000-0002-2921-7583)
- Di Zhou (ORCID: https://orcid.org/0000-0002-9766-860X)
- Xiaomo Wang (ORCID: https://orcid.org/0009-0006-1159-3675)
- Shuohua Chen
- Yang Zhou (ORCID: https://orcid.org/0000-0002-2945-882X)
Institutions
- Hengshui University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Kailuan General Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2024-08-15
- DOI
- https://doi.org/10.1210/clinem/dgae546
- Citations
- 3
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.16